RANTES -28G delays and DC-SIGN -139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs

AIDS Research and Human Retroviruses

Volumn 23, Issue 5, 2007, Pages 713-719

  Koizumi, Yusuke ^a,b   Kageyama, Seiji ^a   Fujiyama, Yoshihide ^b   Miyashita, Michiko ^a   Lwembe, Raphael ^a   Ogino, Keiki ^a   Shioda, Tatsuo ^c   Ichimura, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GENOMIC DNA; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 4; RANTES; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; DENDRITIC CELL; DISEASE COURSE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; JAPANESE; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELL ADHESION MOLECULES; DISEASE PROGRESSION; GENE FREQUENCY; HEMOPHILIA A; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-4; JAPAN; LECTINS, C-TYPE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RANTES; RECEPTORS, CELL SURFACE;

EID: 34249873809     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0225     Document Type: Article

References (36)

1. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 corecepter accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
2. Samson M, Libert F, Doranz BJ, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
3. Dean M, Carrington M, Winkler C, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862.
4. Smith MW, Dean M, Carrington M, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-965.
5. Balotta C, Bagnarelli P, Corvasce S, et al.: Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999;180:285-289.
6. Meyer L, Magierowska M, Hubert JB, et al.: CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 1999;13:624-626.
7. Nakayama EE, Meyer L, Iwamoto A. et al.: Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: Relationship with virus load. J Infect Dis 2002; 185:1183-1186.
8. McDermott DH, Beecroft MJ, Kleeberger CA, et al.: Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000;14:2671-2678.
9. Kageyama S, Mimaya J, Yamada K, Kurimura T, Shiraki K, and Research Committee on Prevention of Developing Illness and Therapy for HIV-infected People: Polymorphism of CCR5 affecting HIV disease progression in the Japanese population. AIDS Res Hum Retroviruses 2001;17:991-995.
10. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
11. Arenzana-Seisdedos F, Virelizier JL, Rousset D, et al.: HIV blocked by chemokine antagonist. Nature 1996;383:400.
12. Liu H, Chao D, Nakayama EE, et al.: Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999;96:4581-4585.
13. An P, Nelson GW, Wang L, et al.: Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002;99:10002-10007.
14. Gonzalez E, Dhanda R, Bamshad M, et al.: Global survey of genetic variation in CCR5, RANTES and MIP-1a: Impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001;98:5199-5204.
15. Bleul CC, Farzan M, Choe H, et al.: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
16. Oberlin E, Amara A, Bachelerie F, et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-835.
17. Forster R, Kremmer E, Schubel A, et al.: Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: Rapid internalization and recycling upon activation. J Immunol 1998;160:1522-1531.
18. Amara A, Gall SL, Schwartz O, et al.: HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:139-146.
19. Bermejo M, Martin-Serrano J, Oberlin E, et al.: Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol 1998;28:3192-3204.
20. Vasilescu A, Heath SC, Ivanova R, et al.: Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: Identification of IL4 and ILI0 haplotypes associated with the disease progression. Genes Immun 2003;4:441-449.
21. Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, and Schuitemaker H: Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants. AIDS 2003;17:981-985.
22. Modi WS, Goedert JJ, Strathdee S, et al.: MCP-1-MPC-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 2003;17:2357-2365.
23. Martin MP, Lederman MM, Hutcheson HB, et al.: Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type infection. J Virol 2004;78:14053-14056.
24. Barreiro LB, Neyrolles O, Babb CL, et al.: Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 2005;3:e20.
25. Sakuntabhai A, Turbpaiboon C, Casad ont I, et al.: A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005:37:507-513.
26. Centers for Disease Control and Prevention, Revision of the CDC surveillance case definition for Acquired Immunodeficiency Syndrome. Morb Mortal Wkly Rep 1987;36(Suppl. 1):1S-15S.
27. Nakayama EE, Hoshino Y, Xin X, et al.: Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol 2000; 74:5452-5459.
28. Winkler C, Modi W, Smith MW, et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279:389-393.
29. Mummidi S, Ahuja SS, Gonzalez E, et al.: Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4: 786-793.
30. Soriano A, Martinez C, Garcia F, et al.: Plasma stromal cell-derived factor (SDF)-1 levels. SDF1-3′ A genotype, and expression of CXCR4 on T lymphocytes: Their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002;186:922-931.
31. Ioannidis JP, Rosenberg PS, Goedert JJ, et al.: Effects of CCR5-delta32, CCR2-64I, and SDF-1 3′ A alleles on HIV-1 disease progression: An international meta-analysis of individual patient data. Ann Intern Med 2001;135:782-795.
32. Modi WS, Scott K, and Goedert JJ: Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun 2005;6:691-698.
33. Valentin A, Lu W, Rosati M, et al.: Dual effect of interleukin 4 on HIV-1 expression: Implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci USA 1998;95:8886-8891.
34. Wang J, Harada A. Matsushita S, et al.: IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J Leukoc Biol 1998;64:642-649.
35. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
36. Liu H, Yu W, Liou LY. and Rice AP: Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters. Gene 2003;313:149-159.